Electromagnetic Geoservices ASA (OSL:EMGS)

Inozyme Pharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	244	268	334	210	156	170
Market Cap Growth	-12.39%	-19.61%	59.18%	34.40%	-8.31%	-37.80%
Enterprise Value	407	368	449	433	341	548
Last Close Price	1.86	2.05	2.55	1.60	1.19	1.30
PE Ratio	3.29	8.38	-	1.90	3.60	-
Forward PE	-	2.02	2.02	2.02	2.02	2.02
PS Ratio	0.67	0.96	4.12	0.61	0.61	0.80
PB Ratio	5.78	6.91	54.80	2.45	-7.05	-2.68
P/TBV Ratio	62.25	-	-	3.01	-	-
P/FCF Ratio	3.73	2.63	8.22	1.31	0.75	-
P/OCF Ratio	3.52	2.58	6.65	1.29	0.75	-
EV/Sales Ratio	1.12	1.31	5.55	1.26	1.34	2.57
EV/EBITDA Ratio	2.26	3.05	-	2.26	2.52	-
EV/EBIT Ratio	3.84	5.77	-	3.35	4.20	-
EV/FCF Ratio	6.23	3.61	11.06	2.70	1.64	-
Debt / Equity Ratio	5.37	6.49	36.47	2.87	-12.35	-5.90
Debt / EBITDA Ratio	1.26	1.75	25.11	1.04	1.54	7.27
Debt / FCF Ratio	3.46	2.47	5.47	1.54	1.32	-
Asset Turnover	1.20	0.86	0.23	0.84	0.61	0.31
Inventory Turnover	3.87	2.39	0.30	1.06	0.82	0.91
Quick Ratio	0.57	0.47	1.55	1.38	1.15	0.87
Current Ratio	0.71	0.63	2.12	1.68	1.54	1.92
Return on Equity (ROE)	1873.48%	140.23%	-176.21%	362.96%	-	-546.76%
Return on Assets (ROA)	21.90%	12.21%	-10.83%	19.79%	12.19%	-8.05%
Return on Capital (ROIC)	28.95%	14.61%	-13.59%	26.37%	17.73%	-12.62%
Return on Capital Employed (ROCE)	249.90%	162.50%	-	46.40%	34.00%	-
Earnings Yield	31.27%	11.93%	-24.83%	52.55%	27.78%	-117.72%
FCF Yield	26.80%	37.98%	12.16%	76.27%	132.95%	-12.43%
Buyback Yield / Dilution	-	-	0.13%	0.00%	-0.13%	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.